HIV and anal cancer outcomes: A single institution's experience

Diseases of the Colon and Rectum

Volumn 52, Issue 5, 2009, Pages 891-897

  Hogg, Melissa E ^a   Popowich, Daniel A ^a   Wang, Ed C ^a   Kiel, Kristina D ^a   Stryker, Steven J ^a   Halverson, Amy L ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University Feinberg School of Medicine ^*  (United States)

Author keywords

Anal canal cancer; Combined modality therapy; HIV; Squamous cell carcinoma

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CAPECITABINE; CISPLATIN; FLUOROURACIL; MITOMYCIN C; MITOXANTRONE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; MITOMYCIN;

ADULT; ANUS CANCER; ANUS CARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COLOSTOMY; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FEMALE; FIBROSIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TOXICITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; RADIATION INJURY; RECURRENT CANCER; RETROSPECTIVE STUDY; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; STENOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; VAGINA DISEASE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ANUS TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COLOSTOMY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; MITOXANTRONE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 67651165227     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e31819eefa6     Document Type: Article

References (28)

1. Daling JR, Madeleine MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004;101:270-80.
2. Maggard MA, Beanes SR, Ko CY. Anal canal cancer: a population-based reappraisal. Dis Colon Rectum 2003;46: 1517-24.
3. Rousseau DL Jr, Thomas CR Jr, Petrelli NJ, Kahlenberg MS. Squamous cell carcinoma of the anal canal. Surg Oncol 2005;14:121-32.
4. Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003;89:1221Y7. (Pubitemid 37363407)
5. Chiao EY, Krown SE, Stier EA, Schrag D. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr 2005;40:451Y5. (Pubitemid 41669180)
6. Lorenz HP, Wilson W, Leigh B, et al. Squamous cell carcinoma of the anus and HIV infection. Dis Colon Rectum 1991;34:336-8.
7. Svensson C, Kaigas M, Lidbrink E, Goldman S. Carcinoma of the anal canal in a patient with AIDS. Acta Oncol 1991;30:986-7.
8. Bottomley DM, Aqel N, Selvaratnam G, Phillips RH. Epidermoid anal cancer in HIV infected patients. Clin Oncol (R Coll Radiol) 1996;8:319Y22. (Pubitemid 26382029)
9. Chadha M, Rosenblatt EA, Malamud S, et al. Squamous-cell carcinoma of the anus in HIV-positive patients. Dis Colon Rectum 1994;37:861Y5. (Pubitemid 24281918)
10. Holland JM, Swift PS. Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy. Radiology 1994;193:251-4.
11. Nasti G, Santarossa S, Vaccher E, et al. Anal cancer in patients with HIV infection: a report of two cases without evidence of immunological dysfunction. AIDS 1994;8:1507Y8. (Pubitemid 24296816)
12. Harrison M, Tomlinson D, Stewart S. Squamous cell carcinoma of the anus in patients with AIDS. Clin Oncol (R Coll Radiol) 1995;7:50-1.
13. Hocht S, Wiegel T, Kroesen AJ, et al. Low acute toxicity of radiotherapy and radiochemotherapy in patients with cancer of the anal canal and HIV-infection. Acta Oncol 1997;36: 799Y802. (Pubitemid 28088464)
14. Peddada AV, Smith DE, Rao AR, et al. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1997;37:1101-5.
15. Hoffman R, Welton ML, Klencke B, et al. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys 1999;44:127Y31. (Pubitemid 29186199)
16. Cleator S, Fife K, Nelson M, et al. Treatment of HIVassociated invasive anal cancer with combined chemoradiation. Eur J Cancer 2000;36:754Y8. (Pubitemid 30179747)
17. Kim JH, Sarani B, Orkin BA, et al. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. Dis Colon Rectum 2001;44: 1496Y502. (Pubitemid 32952556)
18. Place RJ, Gregorcyk SG, Huber PJ, Simmang CL. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum 2001;44:506-12.
19. Vatra B, Sobhani I, Aparicio T, et al. Anal canal squamous-cell carcinomas in HIV positive patients: clinical features, treatments and prognosis. Gastroenterol Clin Biol 2002;26:150Y6. (Pubitemid 34267134)
20. Stadler RF, Gregorcyk SG, Euhus DM, et al. Outcome of HIVinfected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy. Dis Colon Rectum 2004;47:1305-9.
21. Bower M, Powles T, Newsom-Davis T, et al. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr 2004;37:1563-5.
22. Blazy A, Hennequin C, Gornet JM, et al. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy. Dis Colon Rectum 2005;48:1176Y81. (Pubitemid 40897861)
23. Edelman S, Johnstone PA. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities. Int J Radiat Oncol Biol Phys 2006;66:206Y11. (Pubitemid 44175642)
24. Wexler A, Berson AM, Goldstone SE, et al. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum 2008;51:73-81.
25. Ajani JA, Winter KA, Gunderson LL, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 2008;299:1914-21.
26. Watkins EB, Findlay P, Gelmann E, et al. Enhanced mucosal reactions in AIDS patients receiving oropharyngeal irradiation. Int J Radiat Oncol Biol Phys 1987;13:1403Y8. (Pubitemid 17135027)
27. Cooper JS, Fried PR, Laubenstein LJ. Initial observations of the effect of radiotherapy on epidemic Kaposi's sarcoma. JAMA 1984;252:934-5.
28. Cress RD, Holly EA. Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973-1999. Prev Med 2003;36:555-60.